HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
OMCL
Omnicell Inc
Healthcare Health Information Services · California, USA · Reports in usd
Market Cap: $1.86B
Market Cap
$1.86B
Enterprise Val
$1.85B
P/E Ratio
905.84
P/B Ratio
1.51
Trailing PEG (1Y)
-7.90
As Of
Apr 29, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$1.23B
Gross Margin41.51%
Profit Margin41.51%
Return on Equity0.17%
Return on Assets0.10%
Current Ratio1.43
Debt/Equity0.16
LT Debt/Equity0.16
Revenue Per Share7.00

Income Statement

Dec 31, 2025
Revenue$314.0M
Cost of Revenue$183.7M
Gross Profit$130.3M
R&D$22.6M
SG&A$107.4M
Operating Expenses$129.9M
Operating Income$415.0K
Interest Expense-$284.0K
Tax Expense$2.7M
Net Income-$2.0M
EPS (Basic)$-0.05
EPS (Diluted)$-0.05
EBIT$415.0K
EBITDA$22.2M
Consolidated Income-$2.0M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$196.5M
Accounts Receivable$216.9M
Inventory$100.9M
Current Assets$680.1M
LT Investments$60.7M
Property, Plant & Equipment$144.5M
Intangibles$908.1M
Non-Current Assets$1.29B
Total Assets$1.97B
Accounts Payable$44.0M
Current Debt$0.00
Current Liabilities$476.6M
LT Debt$192.4M
Non-Current Liabilities$266.3M
Total Liabilities$742.9M
Total Debt$192.4M
Retained Earnings$384.9M
Shareholder Equity$1.23B
Shares Outstanding44,876,522

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$30.4M
Investing Cash Flow-$14.4M
Financing Cash Flow$9.1M
CapEx-$12.0M
Free Cash Flow$18.4M
Depreciation & Amort.$21.8M
Stock-Based Comp$12.0M
Acquisitions / Disposals-$2.4M
Investment Activity$0.00
Debt Issued/Repaid$0.00
Equity Issued/Repaid$1.7M
Dividends Paid$0.00
Net Change in Cash$25.6M
Data cached · Meta live · Daily live · Statements live · TTL 24h